跳至主要内容
临床试验/NCT02240641
NCT02240641终止不适用

Study on Protective Effect of Caldine® on Renal Function in Patients With a Balanced Hypertension

Boehringer Ingelheim0 个研究点目标入组 5,417 人开始时间: 1998年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
5,417
主要终点
Number of patients with adverse events

研究概览

简要总结

The study aimed at comparing the evolution of renal function in patients showing a hypertension treated by various therapeutic strategies.

Due to the contract research organisation (CRO) decision in September 2000, the database was locked and not accessible for Boehringer Ingelheim France. Consequently it was decided to stop the study and not proceed to the analysis. Thus, only safety data were processed in the safety database.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with hypertension requiring treatment

排除标准

  • 未提供

研究组 & 干预措施

hypertension treatment strategies

干预措施: Lacidipine (Drug)

hypertension treatment strategies

干预措施: Diuretics (Drug)

hypertension treatment strategies

干预措施: antihypertensive drugs (Drug)

hypertension treatment strategies

干预措施: alpha blockers (Drug)

hypertension treatment strategies

干预措施: Angiotensin-Converting Enzyme Inhibitors (Drug)

hypertension treatment strategies

干预措施: beta blockers (Drug)

结局指标

主要结局

Number of patients with adverse events

时间窗: up to two years

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验